Meeting to Discuss Needs of "Lost Generation" of Sickle Cell Patients
The nations first-ever meeting to discuss the need for comprehensive care of adult sickle cell anemia patients will be held in Cincinnati April 78.
The National Adult Sickle Cell Providers Symposium, which will be attended by about 300 scientists and care providers from around the country, is sponsored by UC and the Sickle Cell Adult Provider Network.
Sickle cell disease, an inherited blood disorder, affects about 72,000 Americans and one in 500 African Americans. It is characterized by episodes of pain, chronic anemia and severe infections that usually begin in early childhood. As yet there is no cure.
For about 35 years, symposium organizers say, the emphasis of sickle cell care has been on children, through federally funded Pediatric Comprehensive Sickle Cell Care Centers. The centers have contributed to longevity and improved the lives of thousands of children with sickle cell disease.
These children, however, are now aged 30 to 40 and older, says Zahida Yasin, MD, director of the Adult Sickle Cell Program at UC, and there are few adult care centers to treat them.
These patients have become a lost generation, says Dr. Yasin. At this time in their lives they not only face the continuing battle with sickle cell disease, but also the additional health issues of middle age, such as heart disease, diabetes and high blood pressure, she says.
Their problems are not only very prevalent, but also much more severe than in non-sickle patients, says Dr. Yasin, who is program director for the symposium. Depression and other psychological conditions associated with chronic illness and lack of support systems are rampant.
Compounding the problem is the fact that many adult patients are poor, without families and often intermittently homeless. They also frequently have had a lifelong need for pain-killing drugs, which makes them susceptible to predators on the street, Dr. Yasin says.
Today we dont have the resources to provide comprehensive care for the majority of adult patients with sickle cell disease in the United States, says Dr. Yasin. Were hoping this conference will go at least part of the way to increasing awareness of the problem.
The April 7 sessions will be held at the National Underground Railroad Museum Freedom Center in downtown Cincinnati. The April 8 program will be at the Northern Kentucky Convention Center.
For more information call Georgia Scheben at 513-584-6178. Register online at
www.conferencing.uc.edu/sicklecell
.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.